ClinicalTrials.govpublic full text
Human AntiCD19 Chimeric Antigen Receptor T Cells for Relapsed or Refractory Lymphoid Malignancies
non hodgkin lymphoma, acute lymphoblastic leukemia, chronic lymphocytic leukemia
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 353289
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.